These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6346540)

  • 1. [Anthracycline cardiotoxicity: review].
    Ribera JM; Montserrat E; Rozman C
    Sangre (Barc); 1983; 28(1):54-68. PubMed ID: 6346540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
    Mortensen SA; Aabo K; Jonsson T; Baandrup U
    Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiotoxicity of anthracyclines.
    Green MD; Speyer JL; Muggia FM
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):293-6. PubMed ID: 6584310
    [No Abstract]   [Full Text] [Related]  

  • 7. Anthracycline analogs: re-assessments and prospects.
    Carter SK
    Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion].
    Orditura M; De Vita F; Ciaramella F; Catalano G
    Ann Ital Med Int; 1994; 9(4):243-8. PubMed ID: 7893575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 11. Anthracycline cardiotoxicity: new insights.
    Mushlin PS; Olson RD
    Ration Drug Ther; 1988 Dec; 22(12):1-9. PubMed ID: 3256005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiotoxicity of anthracyclines].
    Laurent S; Colbert N; Izrael V; Motte G
    Ann Med Interne (Paris); 1984; 135(6):464-72. PubMed ID: 6391323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring for anthracycline cardiotoxicity: an introduction.
    McGuire WP
    Cancer Treat Rep; 1978 Jun; 62(6):855. PubMed ID: 667858
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia.
    Cortex EP; Ellison RR; Yates JW
    Cancer Chemother Rep; 1972 Apr; 56(2):237-43. PubMed ID: 4504970
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthracycline associated cardiac toxicity in children with malignancies.
    Mohta R; Saxena A; Jain Y; Gupta S; Thavaraj V; Narain S; Arya LS
    Indian Pediatr; 2002 Jun; 39(6):549-55. PubMed ID: 12084948
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of anthracycline cardiotoxicity.
    Bristow MR; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Oct; 62(10):1607-8. PubMed ID: 709565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiologic sequelae of cytostatic therapy].
    Mladosievivcová B
    Cas Lek Cesk; 2001 Mar; 140(5):138-41. PubMed ID: 11347200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of anthracycline-induced cardiotoxicity.
    Jannazzo A; Hoffman J; Lutz M
    Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
    Menna P; Recalcati S; Cairo G; Minotti G
    Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.